These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines. Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity. Si YG; Gardner MP; Tarazi FI; Baldessarini RJ; Neumeyer JL J Med Chem; 2008 Feb; 51(4):983-7. PubMed ID: 18251489 [TBL] [Abstract][Full Text] [Related]
7. R and S enantiomers of 11-hydroxy- and 10,11-dihydroxy-N-allylnoraporphine: synthesis and affinity for dopamine receptors in rat brain tissue. Neumeyer JL; Gao YG; Kula NS; Baldessarini RJ J Med Chem; 1991 Jan; 34(1):24-8. PubMed ID: 1671415 [TBL] [Abstract][Full Text] [Related]
8. S-(+)-aporphines are not selective for human D3 dopamine receptors. Kula NS; Baldessarini RJ; Kebabian JW; Neumeyer JL Cell Mol Neurobiol; 1994 Apr; 14(2):185-91. PubMed ID: 7842476 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and potency comparisons among aporphine enantiomers: effects on dopamine neurons in substantia nigra of rat. Martin LP; Cox RF; Waszczak BL Neuropharmacology; 1990 Feb; 29(2):135-43. PubMed ID: 2184376 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. Cox RF; Waszczak BL Brain Res; 1993 Jun; 613(1):32-42. PubMed ID: 8102308 [TBL] [Abstract][Full Text] [Related]
12. Aporphines as antagonists of dopamine D-1 receptors. Schaus JM; Titus RD; Foreman MM; Mason NR; Truex LL J Med Chem; 1990 Feb; 33(2):600-7. PubMed ID: 2405158 [TBL] [Abstract][Full Text] [Related]
13. Selective action of two aporphines at alpha 1-adrenoceptors and potential-operated Ca2+ channels. Ivorra MD; ChuliĆ” S; Lugnier C; D'Ocon MP Eur J Pharmacol; 1993 Feb; 231(2):165-74. PubMed ID: 8384112 [TBL] [Abstract][Full Text] [Related]
14. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors. Tarazi FI; Yeghiayan SK; Baldessarini RJ; Kula NS; Neumeyer JL Neuropsychopharmacology; 1997 Sep; 17(3):186-96. PubMed ID: 9272485 [TBL] [Abstract][Full Text] [Related]
15. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain. Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740 [TBL] [Abstract][Full Text] [Related]
16. Aporphines. 15. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain. Miller RJ; Kelly PH; Neumeyer JL Eur J Pharmacol; 1976 Jan; 35(1):77-83. PubMed ID: 943290 [TBL] [Abstract][Full Text] [Related]
18. Intramembrane interactions between neurotensin receptors and dopamine D2 receptors as a major mechanism for the neuroleptic-like action of neurotensin. Fuxe K; Von Euler G; Agnati LF; Merlo Pich E; O'Connor WT; Tanganelli S; Li XM; Tinner B; Cintra A; Carani C Ann N Y Acad Sci; 1992; 668():186-204. PubMed ID: 1361113 [TBL] [Abstract][Full Text] [Related]